Literature DB >> 18698078

Exon 8 splice site mutations in the gene encoding the E3-ligase CBL are associated with core binding factor acute myeloid leukemias.

Saman Abbas, Gabriëlle Rotmans, Bob Löwenberg, Peter J M Valk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18698078     DOI： 10.3324/haematol.13187

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  25 in total

Review 1.  Cbl and human myeloid neoplasms: the Cbl oncogene comes of age.

Authors:  Stephen C Kales; Philip E Ryan; Marion M Nau; Stanley Lipkowitz
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins.

Authors:  Scott Nadeau; Wei An; Nick Palermo; Dan Feng; Gulzar Ahmad; Lin Dong; Gloria E O Borgstahl; Amarnath Natarajan; Mayumi Naramura; Vimla Band; Hamid Band
Journal:  Biochem Anal Biochem       Date:  2012-07-30

3.  CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.

Authors:  Paula Aranaz; Cristina Hurtado; Ignacio Erquiaga; Itziar Miguéliz; Cristina Ormazábal; Ion Cristobal; Marina García-Delgado; Francisco Javier Novo; José Luis Vizmanos
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

4.  Peptide truncation leads to a twist and an unusual increase in affinity for casitas B-lineage lymphoma tyrosine kinase binding domain.

Authors:  Eric A Kumar; Ziyan Yuan; Nicholas Y Palermo; Lin Dong; Gulzar Ahmad; G L Lokesh; Carol Kolar; Smitha Kizhake; Gloria E O Borgstahl; Hamid Band; Amarnath Natarajan
Journal:  J Med Chem       Date:  2012-03-19       Impact factor: 7.446

Review 5.  Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms.

Authors:  Seishi Ogawa; Masashi Sanada; Lee-Young Shih; Takahiro Suzuki; Makoto Otsu; Hiromitsu Nakauchi; H Philip Koeffler
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

Review 6.  Unraveling the molecular pathophysiology of myelodysplastic syndromes.

Authors:  Rafael Bejar; Ross Levine; Benjamin L Ebert
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

7.  As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia.

Authors:  Jian-Hua Mao; Xiao-Yan Sun; Jian-Xiang Liu; Qun-Ye Zhang; Ping Liu; Qiu-Hua Huang; Keqin Kathy Li; Quan Chen; Zhu Chen; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

8.  Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

Authors:  Hideki Makishima; Heather Cazzolli; Hadrian Szpurka; Andrew Dunbar; Ramon Tiu; Jungwon Huh; Hideki Muramatsu; Christine O'Keefe; Eric Hsi; Ronald L Paquette; Seiji Kojima; Alan F List; Mikkael A Sekeres; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

9.  Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.

Authors:  Masashi Sanada; Takahiro Suzuki; Lee-Yung Shih; Makoto Otsu; Motohiro Kato; Satoshi Yamazaki; Azusa Tamura; Hiroaki Honda; Mamiko Sakata-Yanagimoto; Keiki Kumano; Hideaki Oda; Tetsuya Yamagata; Junko Takita; Noriko Gotoh; Kumi Nakazaki; Norihiko Kawamata; Masafumi Onodera; Masaharu Nobuyoshi; Yasuhide Hayashi; Hiroshi Harada; Mineo Kurokawa; Shigeru Chiba; Hiraku Mori; Keiya Ozawa; Mitsuhiro Omine; Hisamaru Hirai; Hiromitsu Nakauchi; H Phillip Koeffler; Seishi Ogawa
Journal:  Nature       Date:  2009-07-20       Impact factor: 49.962

10.  Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.

Authors:  Mignon L Loh; Debbie S Sakai; Christian Flotho; Michelle Kang; Manfred Fliegauf; Sophie Archambeault; Charles G Mullighan; Leslie Chen; Eva Bergstraesser; Carlos E Bueso-Ramos; Peter D Emanuel; Henrik Hasle; Jean-Pierre Issa; Marry M van den Heuvel-Eibrink; Franco Locatelli; Jan Stary; Monica Trebo; Marcin Wlodarski; Marco Zecca; Kevin M Shannon; Charlotte M Niemeyer
Journal:  Blood       Date:  2009-07-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.